The mark consists of an image of a mountain on the left with the words "BRUKINSA" to the right and the word "ZANUBRUTINIB" below it.
Mark For: BRUKINSA ZANUBRUTINIB® trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of an image of a mountain on the left with the words "BRUKINSA" to the right and the word "ZANUBRUTINIB" below it.
Research | OneLook Acronym Finder |
Serial Number | 88337582 |
Registration Number | 6252000 |
Mark Literal Elements | BRUKINSA ZANUBRUTINIB |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED 2020-06-09 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Jason M. Okun and Kristen S. Ruisi |
Attorney Docket Number | 140679500075 |
Law Office Assigned | M50 |
Employee Name | KHAN, ASMAT A |
2019-03-13 | Application Filed |
2019-11-21 | Date of First Use |
2019-11-21 | Date of Use In Commerce |
2019-11-22 | Location: PUBLICATION AND ISSUE SECTION |
2019-12-31 | Published |
2019-12-31 | Published for Opposition |
2019-12-31 | Status: Live/Pending |
2019-12-31 | Transaction Date |
2020-06-09 | Location: TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED |
2020-06-09 | Status: A final Office action has been sent (issued) to the applicant after review of the Statement of Use. To view all documents in thi |
2021-01-19 | Trademark Registered |
Party: | BeiGene, Ltd. |
Address | 94 Solaris Avenue, Camana Bay c/o Mourant Ozannes Corporate Services Grand Cayman CAYMAN ISLANDS KY1-1108 |
Legal Entity Type | Corporation |
Legal Entity State | CAYMAN ISLANDS |
060104 | Mountains (landscapes); Scenery with mountains |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases. FIRST USE: 20191121. FIRST USE IN COMMERCE: 20191121
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
SU - FINAL REFUSAL - WRITTEN | 2020-06-09 | 74818 |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-06-09 | |
FINAL REFUSAL E-MAILED | 2020-06-09 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-21 | 74221 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-21 | 74221 |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2020-04-16 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-04-16 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-16 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-04-16 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-04-16 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-04-16 | 74221 |
SU - NON-FINAL ACTION - WRITTEN | 2020-04-11 | 74818 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-04-11 | |
NON-FINAL ACTION E-MAILED | 2020-04-11 | |
STATEMENT OF USE PROCESSING COMPLETE | 2020-03-23 | 76538 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-03-23 | 76538 |
USE AMENDMENT FILED | 2020-03-04 | 76538 |
TEAS STATEMENT OF USE RECEIVED | 2020-03-04 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-02-25 | |
PUBLISHED FOR OPPOSITION | 2019-12-31 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-12-31 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-12-11 | |
ASSIGNED TO LIE | 2019-11-20 | 74221 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-11-19 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-11-15 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2019-11-15 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2019-11-15 | 74818 |
EXAMINER'S AMENDMENT ENTERED | 2019-11-15 | 88888 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-11-12 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-11-12 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-11-12 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-05-29 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-05-29 | 74818 |
NON-FINAL ACTION E-MAILED | 2019-05-29 | 6325 |
ASSIGNED TO EXAMINER | 2019-05-22 | 74818 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2019-04-02 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-31 | |
NEW APPLICATION ENTERED IN TRAM | 2019-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.